Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal. 2023;44(38):3720-826. doi: 10.1093/eurheartj/ehad191..
DOI: 10.1093/eurheartj/ehad191

Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2020. Российское кардиологическое общество, Ассоциация сердечно-сосудистых хирургов России. Российский кардиологический журнал. 2020;25(11):4103. doi: 10.15829/1560-4071-2020-4103..
DOI: 10.15829/1560-4071-2020-4103

Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114:2019-25. doi: 10.1161/circulationaha.106.638353..
DOI: 10.1161/circulationaha.106.638353

Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003;92: 824-6. doi: 10.1016/s0002-9149(03)00891-9..
DOI: 10.1016/s0002-9149(03)00891-9

Betriu A, Masotti M. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis. Am J Cardiol. 2005;95:100-1. doi: 10.1016/j.amjcard.2004.08.069..
DOI: 10.1016/j.amjcard.2004.08.069

Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. European Heart Journal. 2006;27:779-8. doi: 10.1093/eurheartj/ehi810..
DOI: 10.1093/eurheartj/ehi810

Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011;124:2512-21. doi: 10.1161/circulationaha.111.018549..
DOI: 10.1161/circulationaha.111.018549

Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379-87. doi: 10.1056/NEJMoa1301092..
DOI: 10.1056/NEJMoa1301092

Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. doi: 10.1016/s0140-6736(03)12113-7..
DOI: 10.1016/s0140-6736(03)12113-7

Huynh T, Perron S, O'Loughlin J, et al. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: Bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation. 2009;119:3101-9. doi: 10.1161/circulationaha.108.793745..
DOI: 10.1161/circulationaha.108.793745

Writing Committee Members, Antman EM, Anbe DT, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Journal of the American College of Cardiology. 2004;44(3);671-719. doi: 10.1016/j.jacc.2004.07.002..
DOI: 10.1016/j.jacc.2004.07.002

Writing Committee Members, O'Gara PT, Kushner FG, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362-e425. doi: 10.1161/CIR.0b013e3182742cf6..
DOI: 10.1161/CIR.0b013e3182742cf6

Steg G, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33(20):2569-619. doi: 10.1093/eurheartj/ehs215..
DOI: 10.1093/eurheartj/ehs215

Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2): 119-77. doi: 10.1093/eurheartj/ehx393..
DOI: 10.1093/eurheartj/ehx393

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet. 1994;343(8893):311-22. doi: 10.1016/S0140-6736(94)91161-4..
DOI: 10.1016/S0140-6736(94)91161-4

Le May MR, Wells GA, Labinaz M, et al. Combined Angioplasty and Pharmacological Intervention Versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL-AMI Study). Journal of the American College of Cardiology. 2005;46(3):417-24. doi: 10.1016/j.jacc.2005.04.042..
DOI: 10.1016/j.jacc.2005.04.042

Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367(9510):569-78. doi: 10.1016/S0140-6736(06)68147-6..
DOI: 10.1016/S0140-6736(06)68147-6

Steg PG, Danchin N. WEST: new data on the integration of early thrombolysis and mechanical intervention in the early management of STEMI. European Heart Journal. 2006;27(13):1511-2. doi: 10.1093/eurheartj/ehl107..
DOI: 10.1093/eurheartj/ehl107

Fernández-Avilés F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004;364(9439):1045-53. doi: 10.1016/S0140-6736(04)17059-1..
DOI: 10.1016/S0140-6736(04)17059-1

Fernández-Avilés F, Alonso JJ, Peña G, et al. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. European Heart Journal. 2007;28(8):949-60. doi: 10.1093/eurheartj/ehl461..
DOI: 10.1093/eurheartj/ehl461

Arbel Y, Ko DT, Yan AT, et al. Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Can J Cardiol. 2018;34(6):736-43. doi: 10.1016/j.cjca.2018.02.005..
DOI: 10.1016/j.cjca.2018.02.005

Bøhmer E, Hoffmann P, Abdelnoor M, et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol. 2010;55(2):102-10. doi: 10.1016/j.jacc.2009.08.007..
DOI: 10.1016/j.jacc.2009.08.007

Armstrong PW, Gershlick A, Goldstein P, et al. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. Am Heart J. 2010;160(1):30.e1-35.e1. doi: 10.1016/j.ahj.2010.04.007..
DOI: 10.1016/j.ahj.2010.04.007

Van de Werf F, Ristić AD, Averkov OV, et al. STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial. Circulation. 2023;148(9):753-64. doi: 10.1161/CIRCULATIONAHA.123.064521..
DOI: 10.1161/CIRCULATIONAHA.123.064521

Stone GW, Gersh BJ. Facilitated angioplasty: paradise lost. Lancet. 2006;367(9510): 543-6. doi:10.1016/S0140-6736(06)68149-X..
DOI: 10.1016/S0140-6736(06)68149-X

Singh KP, Roe MT. ASSENT-4 PCI: should facilitated percutaneous coronary intervention be used in clinical practice? Nat Clin Pract Cardiovasc Med. 2006;3(8):420-1. doi: 10.1038/ncpcardio0626..
DOI: 10.1038/ncpcardio0626

Fazel R, Joseph TI, Sankardas MA, et al. Comparison of Reperfusion Strategies for ST-Segment-Elevation Myocardial Infarction: A Multivariate Network Meta-analysis. J Am Heart Assoc. 2020;9(12):e015186. doi: 10.1161/JAHA.119.015186..
DOI: 10.1161/JAHA.119.015186

Li K, Zhang B, Zheng B, et al. Reperfusion Strategy of ST-Elevation Myocardial Infarction: A Meta-Analysis of Primary Percutaneous Coronary Intervention and Pharmaco-Invasive Therapy. Front Cardiovasc Med. 2022;9:813325. doi: 10.3389/fcvm.2022.813325..
DOI: 10.3389/fcvm.2022.813325

Bainey KR, Armstrong PW, Zheng Y, et al. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice. Circulation: Cardiovascular Interventions. 2019;12:e008059. doi: 10.1161/CIRCINTERVENTIONS.119.008059..
DOI: 10.1161/CIRCINTERVENTIONS.119.008059

Wong GC, Welsford M, Ainsworth C, et al. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion. Canadian Journal of Cardiology. 2019;35(2):107-32. doi: 10.1016/j.cjca.2018.11.031..
DOI: 10.1016/j.cjca.2018.11.031

Danchin N, Popovic B, Puymirat E, et al. Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmacoinvasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme. European Heart Journal. 2020;41(7):858-66. doi: 10.1093/eurheartj/ehz665..
DOI: 10.1093/eurheartj/ehz665

Jortveit J, Pripp AH, Halvorsen S, et al. Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway. Eur Heart J Cardiovasc Pharmacother. 2022;8(5):442-51. doi: 10.1093/ehjcvp/pvab041..
DOI: 10.1093/ehjcvp/pvab041

Jamal J, Idris H, Faour A, et al. Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention. Eur Heart J. 2023;44(6):516-28. doi: 10.1093/eurheartj/ehac661..
DOI: 10.1093/eurheartj/ehac661

Хохлунов С. М., Прожога М. Г., Гуреев А. Д. Фармакоинвазивная стратегия при лечении острого коронарного синдрома с подъемом сегмента ST на ЭКГ. Известия Самарского научного центра Российской академии наук. 2015;17(2):404-10.

Бойцов С. А., Шахнович Р. М., Терещенко С. Н. и др. Особенности реперфузионной стратегии лечения пациентов с инфарктом миокарда с подъемом сегмента ST по данным Российского регистра острого инфаркта миокарда — РЕГИОН-ИМ. Кардиология. 2024;64(2):3-17. doi: 10.18087/cardio.2024.2.n2601..
DOI: 10.18087/cardio.2024.2.n2601

Эрлих А. Д., Грацианский Н. А. от имени участников регистра РЕКОРД-3. Российский регистр острого коронарного синдрома РЕКОРД-3. Характеристика пациентов и лечение до выписки из стационара. Кардиология. 2016;56(4):16-24. EDN VXCLED.

Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Российский кардиологический журнал. 2025;30. В печати.

Kumar A, Vora K, Bhatt DL, et al. The Canadian Cardiovascular Society Classification of acute atherothrombotic myocardial infarction provides a novel staging scheme based on tissue injury severity. Eur Heart J. 2024;45(12):976-9. doi: 10.1093/eurheartj/ehad821..
DOI: 10.1093/eurheartj/ehad821

Steg PG, Bonnefoy E, Chabaud S, et al. Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108(23):2851-6. doi: 10.1161/01.CIR.0000103122.10021.F2..
DOI: 10.1161/01.CIR.0000103122.10021.F2

Maleki ND, Van de Werf F, Goldstein P, et al. Aborted myocardial infarction in ST-elevation myocardial infarction: insights from the STrategic Reperfusion Early After Myocardial infarction trial. Heart. 2014;100(19):1543-9. doi: 10.1136/heartjnl-2014-306023..
DOI: 10.1136/heartjnl-2014-306023

Marcolino MS, Maia LM, Oliveira JAQ, et al. Impact of telemedicine interventions on mortality in patients with acute myocardial infarction: A systematic review and metaanalysis. Heart. 2019;105:1479-86. doi: 10.1136/heartjnl-2018-314539..
DOI: 10.1136/heartjnl-2018-314539

de Waure C, Cadeddu C, Gualano MR, et al. Telemedicine for the reduction of myocardial infarction mortality: A systematic review and a meta-analysis of published studies. Telemed J E Health. 2012;18:323-8. doi: 10.1089/tmj.2011.0158..
DOI: 10.1089/tmj.2011.0158

Гацко Ю. С., Нохрин А. В., Урванцева И. А. и др. Организация дистанционного консультирования и маршрутизации пациентов с сердечнососудистой патологией в условиях ХМАО-Югры. Современные проблемы здравоохранения и медицинской статистики. 2017;4:200-1.

Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40,87-165. doi: 10.1093/eurheartj/ehy394..
DOI: 10.1093/eurheartj/ehy394

Терещенко А. С., Жамгырчиев Ш. Т., Меркулов Е. В. и др. Трансрадиальный доступ при чрескожных коронарных вмешательствах. Часть 2. Практические рекомендации и собственные данные. Вестник рентгенологии и радиологии. 2014;(2):52-9. doi: 10.20862/0042-4676-2014-0-2-52-59..
DOI: 10.20862/0042-4676-2014-0-2-52-59

Chen P, Eikelboom JW, Tan C, et al. Single Bolus r-SAK Before Primary PCI for ST-Segment—Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions. 2024; 17(2):e013455. doi: 10.1161/CIRCINTERVENTIONS.123.013455..
DOI: 10.1161/CIRCINTERVENTIONS.123.013455

Li C, Eikelboom JW, Zhong Z, et al. Efficacy and safety of a bolus of half-dose r-SAK prior to primary PCI in ST-elevation myocardial infarction: Rationale and design of the OPTIMA-6 trial. Am Heart J. 2023;265:31-9. doi: 10.1016/j.ahj.2023.06.012..
DOI: 10.1016/j.ahj.2023.06.012

Аверков О. В. Тромболитическая терапия инфаркта миокарда. Лечебное дело. 2003;1:21-33.

Марков В. А., Дупляков Д. В., Константинов С. Л. и др. Расширенные результаты применения лекарственного препарата Фортелизин® в исследовании ФРИДОМ1 и реальной клинической практике. Российский кардиологический журнал. 2022;27(8):5178. doi: 10.15829/1560-4071-2022-5178..
DOI: 10.15829/1560-4071-2022-5178

Марков В. А., Дупляков Д. В., Константинов С. Л. и др. Фортелизин® в сравнении с Метализе® при инфаркте миокарда с подъемом сегмента ST: однолетние результаты и клинические исходы многоцентрового рандомизированного исследования ФРИДОМ1. Российский кардиологический журнал. 2018;(11):110-6. doi: 10.15829/1560-4071-2018-11-110-116..
DOI: 10.15829/1560-4071-2018-11-110-116

Калинина А. М., Гомова Т. А., Кушунина Д. В. и др. Профилактическая активность пациентов поликлиник как важный фактор эффективности диспансеризации и диспансерного наблюдения: региональный опыт. Профилактическая медицина. 2015;18(2):4-10. doi: 10.17116/profmed20151824-1..
DOI: 10.17116/profmed20151824-1

Mican J, Toul M, Bednar D, et al. Structural Biology and Protein Engineering of Thrombolytics. Computational and Structural Biotechnology. 2019;17:917-38. doi: 10.1016/j.csbj.2019.06.023..
DOI: 10.1016/j.csbj.2019.06.023